Equities

Allurion Technologies Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
ALUR:NYQ

Allurion Technologies Inc

Actions
Health CareHealth Care Providers
  • Price (USD)0.6841
  • Today's Change-0.017 / -2.42%
  • Shares traded1.09m
  • 1 Year change-76.00%
  • Beta-0.3856
Data delayed at least 15 minutes, as of Mar 03 2026 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.

  • Revenue in USD (TTM)17.21m
  • Net income in USD-34.41m
  • Incorporated2023
  • Employees134.00
  • Location
    Allurion Technologies Inc11 Huron Dr Ste 200NATICK 01760United StatesUSA
  • Phone+1 (508) 647-4000
  • Fax+1 (302) 655-5049
  • Websitehttps://www.allurion.com/en
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Yunji Inc (ADR)49.72m-31.36m7.31m363.00--0.0516--0.1471-6.37-6.3710.1028.770.2525.869.92136,956.10-15.60-3.81-19.36-6.1133.4824.47-61.88-4.111.48-32.020.0152---34.76-48.6325.45--46.86--
GPO Plus Inc5.22m-4.44m7.33m17.00------1.41-0.0691-0.06910.0736-0.06587.5531.2872.09307,014.70-642.53-1,834.37----26.6719.31-85.05-371.730.029-2.36----8.92--12.20------
Treasure Global Inc3.08m-27.44m7.84m12.00--0.4368--2.54-141.59-141.598.8710.720.142424.075.96257,067.50-126.66-247.45-141.59--41.361.93-889.46-32.734.35--0.00---89.4454.10-254.92--112.75--
Vynleads Inc0.00-259.77k7.88m1.00---------0.0146-0.01460.00-0.01780.00----0.00-935.60-647.28-------246.05---2,970.81---38.56--------0.8541------
Amesite Inc288.80k-2.96m7.96m6.00--5.28--27.55-0.6665-0.66650.0650.32980.1397--80.2248,133.33-143.30-92.64-214.99-104.72-----1,025.70-1,315.99----0.00---33.8113.0817.85---13.82--
Abits Group Inc-100.00bn-100.00bn8.13m11.00--0.6265----------4.10----------------------------0.1878--299.11--92.77------
Infobird Co Ltd4.86m-2.88m8.35m55.00--0.1253--1.72-1.02-1.021.628.140.072--1.6488,389.82-4.29-12.93-4.48-18.3338.5164.99-59.59-139.35---2.330.00--413.52-39.8490.07---17.85--
DarkIris Inc10.08m-8.64m8.42m19.00--1.24--0.8359-0.5229-0.52290.59240.337------530,463.20--------24.83---85.75------0.00--27.25---887.94------
OLB Group Inc9.64m-9.77m8.44m15.00--1.05--0.8761-3.45-3.452.190.59970.6854--143.98642,643.30-63.53-37.56-136.43-44.7514.9125.70-92.68-48.92---13.220.0051---58.004.5251.30------
Locafy Ltd2.27m-3.06m8.46m18.00--3.12--3.72-1.84-1.841.381.510.5395--3.83126,168.40-72.67-53.49-112.06-97.63-----134.71-84.79---20.370.1416---22.8510.04-122.27--35.96--
zSpace, Inc.31.55m-21.79m8.52m78.00------0.2702-0.9334-0.93341.35-0.74332.277.087.86404,435.90-156.13------45.49---68.88--0.5619-11.41-----13.26--216.89------
Allurion Technologies Inc17.21m-34.41m8.61m134.00------0.5003-9.20-9.203.07-10.680.49991.632.47128,417.90-99.97---181.21--60.99---199.95--0.9407-9.79-----39.94--68.23------
Mixed Martial Arts Group Ltd977.08k-18.45m8.96m22.00------9.17-1.32-1.320.0701-0.0751------44,412.81-------------1,888.13-----73.16----145.05---80.57------
FDCTECH Inc30.22m1.57m9.13m--5.520.55713.950.30210.00390.00390.07290.03880.6627--180.19--3.43-2.1310.00-6.7953.2341.255.17-3.48--25.850.1991--111.24130.38-94.90---22.33--
Gaxos.ai Inc.694.27k-3.78m9.85m3.00--0.5761--14.19-0.6826-0.68260.1141.980.0649--30.95231,423.30-37.71---38.79-------581.33------0.00--1,450.00--13.42------
Data as of Mar 03 2026. Currency figures normalised to Allurion Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

85.24%Per cent of shares held by top holders
HolderShares% Held
RTW Investments LPas of 31 Dec 20255.89m75.89%
Lunt Capital Management, Inc.as of 31 Dec 2025166.67k2.15%
TD Securities (USA) LLCas of 31 Dec 2025162.00k2.09%
Empery Asset Management LPas of 31 Dec 202559.88k0.77%
Heights Capital Management, Inc.as of 31 Dec 202559.88k0.77%
Hudson Bay Capital Management LPas of 31 Dec 202559.88k0.77%
L1 Global Manager Pty Ltd.as of 31 Dec 202559.88k0.77%
Armistice Capital LLCas of 31 Dec 202559.88k0.77%
Olayan Europe Ltd.as of 31 Dec 202549.70k0.64%
Vanguard Fiduciary Trust Co.as of 31 Dec 202547.74k0.62%
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.